Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELBASVIR vs ELETRIPTAN HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELBASVIR vs ELETRIPTAN HYDROBROMIDE: Safety Overview

Metric ELBASVIR ELETRIPTAN HYDROBROMIDE
Total FAERS Reports 367 2,158
Deaths Reported 58 12
Death Rate 15.8% 0.6%
Hospitalizations 175 271
Average Patient Age 64.1 yrs 52.6 yrs
% Female Patients 73.9% 86.2%
FDA Approval Date N/A Aug 11, 2017
Manufacturer Merck Sharp & Dohme LLC Zydus Pharmaceuticals USA Inc.
Route ORAL ORAL
Marketing Status N/A Prescription